In women treated for endometrial cancer in the US, minimally invasive surgery is associated with substantial decreases in 30-day morbidity, readmission, and reoperation. This according to a retrospective cohort study that compared 30-day surgical outcomes between 12,283 patients who had minimally invasive surgery and open surgery from 2008 to 2014. Researchers found:
- During the study period, a significant implementation of minimally invasive surgery (24.2% to 71.4%) and a concomitant decrease in open surgery through laparotomy were observed.
- Rate of vaginal surgery did not change over time.
- After adjusting for possible confounders, open surgery (vs minimally invasive surgery) was independently associated with increased odds of major complications, readmission, reoperation, superficial surgical site infection, perioperative transfusion, and death.
- There was a comprehensive decrease in 30-day morbidity for the treatment of endometrial cancer overall; 30-day mortality remained unchanged.
Casarin J, Multinu F, Ubl D, et al. Adoption of minimally invasive surgery and decreased in surgical morbidity for endometrial cancer treatment in the United States. [Published online ahead of print January 9, 2018]. Obstet Gynecol. doi:10.1097/AOG.0000000000002428.
This Week's Must Reads
Must Reads in Gynecologic Cancer
Maternal Factors in Cervical Cancer Prevention, Womens Health Issues; ePub 2019 Jan 10; Charlton, et al
Combined Gynecologic Ca & Pelvic Floor Dysfunction Surgery, Female Pelvic Med Reconstr Surg; ePub 2018 Oct 22; McConnell, et al